BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34743296)

  • 1. Subjective cognitive decline-related worries modulate the relationship between global amyloid load and gray matter volume in preclinical Alzheimer's disease.
    Wang X; Wang M; Wang X; Zhou F; Jiang J; Liu H; Han Y
    Brain Imaging Behav; 2022 Jun; 16(3):1088-1097. PubMed ID: 34743296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Between the Subjective Cognitive Decline-Questionnaire's Scores, Gray Matter Volume, and Amyloid-β Levels.
    Valech N; Sánchez-Benavides G; Tort-Merino A; Coll-Padrós N; Olives J; León M; Falcon C; Molinuevo JL; Rami L
    J Alzheimers Dis; 2019; 72(4):1287-1302. PubMed ID: 31707366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau-related grey matter network breakdown across the Alzheimer's disease continuum.
    Pelkmans W; Ossenkoppele R; Dicks E; Strandberg O; Barkhof F; Tijms BM; Pereira JB; Hansson O
    Alzheimers Res Ther; 2021 Aug; 13(1):138. PubMed ID: 34389066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial Patterns of Longitudinal Gray Matter Change as Predictors of Concurrent Cognitive Decline in Amyloid Positive Healthy Subjects.
    Araque Caballero MÁ; Klöppel S; Dichgans M; Ewers M;
    J Alzheimers Dis; 2017; 55(1):343-358. PubMed ID: 27662291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer Disease.
    Hönig M; Altomare D; Caprioglio C; Collij L; Barkhof F; Van Berckel B; Scheltens P; Farrar G; Battle MR; Theis H; Giehl K; Bischof GN; Garibotto V; Molinuevo JLL; Grau-Rivera O; Delrieu J; Payoux P; Demonet JF; Nordberg AK; Savitcheva I; Walker Z; Edison P; Stephens AW; Gismondi R; Jessen F; Buckley CJ; Gispert JD; Frisoni GB; Drzezga A;
    Neurology; 2024 Mar; 102(6):e208053. PubMed ID: 38377442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical Amyloid Burden Relates to Basal Forebrain Volume in Subjective Cognitive Decline.
    Daamen M; Scheef L; Li S; Grothe MJ; Gaertner FC; Buchert R; Buerger K; Dobisch L; Drzezga A; Essler M; Ewers M; Fliessbach K; Herrera Melendez AL; Hetzer S; Janowitz D; Kilimann I; Krause BJ; Lange C; Laske C; Munk MH; Peters O; Priller J; Ramirez A; Reimold M; Rominger A; Rostamzadeh A; Roeske S; Roy N; Scheffler K; Schneider A; Spottke A; Spruth EJ; Teipel SJ; Wagner M; Düzel E; Jessen F; Boecker H;
    J Alzheimers Dis; 2023; 95(3):1013-1028. PubMed ID: 37638433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.
    Groot C; Grothe MJ; Mukherjee S; Jelistratova I; Jansen I; van Loenhoud AC; Risacher SL; Saykin AJ; Mac Donald CL; Mez J; Trittschuh EH; Gryglewski G; Lanzenberger R; Pijnenburg YAL; Barkhof F; Scheltens P; van der Flier WM; Crane PK; Ossenkoppele R
    Neuroimage Clin; 2021; 30():102660. PubMed ID: 33895633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project.
    Verfaillie SCJ; Timmers T; Slot RER; van der Weijden CWJ; Wesselman LMP; Prins ND; Sikkes SAM; Yaqub M; Dols A; Lammertsma AA; Scheltens P; Ossenkoppele R; van Berckel BNM; van der Flier WM
    Front Aging Neurosci; 2019; 11():7. PubMed ID: 30760996
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2.
    Yildirim Z; Delen F; Berron D; Baumeister H; Ziegler G; Schütze H; Glanz W; Dobisch L; Peters O; Freiesleben SD; Schneider LS; Priller J; Spruth EJ; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Meiberth D; Buerger K; Janowitz D; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Laske C; Munk MH; Spottke A; Roy N; Heneka M; Brosseron F; Wagner M; Roeske S; Ramirez A; Ewers M; Dechent P; Hetzer S; Scheffler K; Kleineidam L; Wolfsgruber S; Yakupov R; Schmid M; Berger M; Gurvit H; Jessen F; Duzel E
    Alzheimers Res Ther; 2023 Feb; 15(1):43. PubMed ID: 36855049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.
    Tiepolt S; Schäfer A; Rullmann M; Roggenhofer E; ; Gertz HJ; Schroeter ML; Patt M; Bazin PL; Jochimsen TH; Turner R; Sabri O; Barthel H
    J Alzheimers Dis; 2018; 64(2):393-404. PubMed ID: 29865069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer's disease.
    Wirth M; Bejanin A; La Joie R; Arenaza-Urquijo EM; Gonneaud J; Landeau B; Perrotin A; Mézenge F; de La Sayette V; Desgranges B; Chételat G
    Neurobiol Aging; 2018 Mar; 63():140-151. PubMed ID: 29203090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.